General Biologicals Corporation

General Biologicals Corporationverified

4117.TWO

Price:

$12.8

Market Cap:

$778.66M

General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally. It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services. The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma. In addition, it offers a range of oral care products under the oh care brand. Further, the company serves its diagnostic solutions through clinics and laboratories. General Biologicals Corporation was fo...[Read more]

Industry

Medical - Specialties

IPO Date

2007-10-25

Stock Exchange

TWO

Ticker

4117.TWO

The ROE as of December 2025 (TTM) for General Biologicals Corporation (4117.TWO) is -110.52%

According to General Biologicals Corporation’s latest financial reports and current stock price. The company's current ROE is -110.52%. This represents a change of 159.90% compared to the average of -42.52% of the last 4 quarters.

General Biologicals Corporation (4117.TWO) Historical ROE (quarterly & annually)

How has 4117.TWO ROE performed in the past?

The mean historical ROE of General Biologicals Corporation over the last ten years is -27.44%. The current -110.52% ROE has changed 302.69% with respect to the historical average. Over the past ten years (40 quarters), 4117.TWO's ROE was at its highest in in the June 2022 quarter at 0%. The ROE was at its lowest in in the June 2025 quarter at -82.43%.

Quarterly (TTM)
Annual

Average

-27.44%

Median

-23.93%

Minimum

-77.59%

Maximum

9.08%

General Biologicals Corporation (4117.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of General Biologicals Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 421.31%

Maximum Annual ROE = 9.08%

Minimum Annual Increase = -227.66%

Minimum Annual ROE = -77.59%

Quarterly (TTM)
Annual
YearROEChange
2024-77.59%93.22%
2023-40.16%421.31%
2022-7.70%-227.66%
20216.03%-33.54%
20209.08%-116.71%

General Biologicals Corporation (4117.TWO) Average ROE

How has 4117.TWO ROE performed in the past?

The current ROE of General Biologicals Corporation (4117.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-41.82%

5-year avg

-22.07%

10-year avg

-27.44%

General Biologicals Corporation (4117.TWO) ROE vs. Peers

How is 4117.TWO’s ROE compared to its peers?

General Biologicals Corporation’s ROE is greater than Radiant Innovation Inc. (-7.02%), greater than S&S Healthcare Holding Ltd. (-13.66%), greater than Andros Pharmaceuticals Co.,Ltd (-18.09%), less than Healthconn Corp. (1.71%), greater than PlexBio Co., Ltd. (-18.38%), less than Concord Medical Co., Ltd. (7.90%), greater than SynCore Biotechnology Co.,Ltd (-18.31%), greater than TFBS Bioscience Inc. (-4.90%), greater than Eusol Biotech Co.,Ltd. (-10.52%), less than Amed Co., Ltd. (5.43%),

Build a custom stock screener for General Biologicals Corporation (4117.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like General Biologicals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

General Biologicals Corporation (4117.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like General Biologicals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is General Biologicals Corporation's ROE?

How is the ROE calculated for General Biologicals Corporation (4117.TWO)?

What is the highest ROE for General Biologicals Corporation (4117.TWO)?

What is the 3-year average ROE for General Biologicals Corporation (4117.TWO)?

What is the 5-year average ROE for General Biologicals Corporation (4117.TWO)?

How does the current ROE for General Biologicals Corporation (4117.TWO) compare to its historical average?